Literature DB >> 2033275

ELISA for the detection of anticardiolipin antibodies. High specificity based on the use of adult bovine serum as buffer and systematic subtraction of non-specific binding.

A Rupin1, Y Gruel, H Watier, A C Girard, J Leroy, P Bardos.   

Abstract

We have used an ELISA procedure to compare the reactivity of samples with or without IgG anticardiolipin antibodies (ACA) on cardiolipin-coated wells (target wells) and cardiolipin-free wells (control wells), using 10% fetal calf serum (10% FCS), 10% adult bovine serum (10% ABS) or 1% bovine serum albumin (1% BSA) as buffer. With 1% BSA, ACA reactivity was very low which suggests that this buffer would be inappropriate for use in ELISA procedures for ACA. 10% FCS induced non-specific binding of normal IgG only on target wells, particularly in the case of IgG hypergammaglobulinemia. With 10% ABS, this non-specific binding occurred on the solid phase with and without cardiolipin and could be accurately evaluated by subtracting the absorbance of control wells. Results of assays on 35 systemic lupus erythematosus sera using 10% ABS as buffer showed that highly specific results-could be obtained only if non-specific binding was systematically subtracted.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033275     DOI: 10.1016/0022-1759(91)90170-k

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up.

Authors:  M Liedorp; E Sanchez; I M W van Hoogstraten; B M E von Blomberg; F Barkhof; C H Polman; J Killestein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10       Impact factor: 10.154

2.  Epidemiological study air disaster in Amsterdam (ESADA): study design.

Authors:  Pauline Slottje; Anja C Huizink; Jos W R Twisk; Anke B Witteveen; Henk M van der Ploeg; Inge Bramsen; Nynke Smidt; Joost A Bijlsma; Lex M Bouter; Willem van Mechelen; Tjabe Smid
Journal:  BMC Public Health       Date:  2005-05-30       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.